Neuropharmaceutical that eliminates the chronic itching of Psoriasis
AntalGenics has raised €808k across 1 funding round from 4 investors, most recently a Crowdfunding round in Feb 2022. Based in Elche, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-16 | Crowdfunding |
| €808k |
| Antonio Ferrer,Antonio Parente,Capital Cell,Inveready |
| View deal → |
